Szatmari S[au] - Search Results

Year	Number of Results
1975	1
1985	1
1989	1
1990	2
1994	1
1996	1
1997	1
1999	1
2002	2
2003	2
2006	1
2007	1
2008	1
2009	1
2010	2
2012	4
2013	7
2014	3
2015	2
2016	5
2017	7
2018	2
2019	10
2020	7
2021	3
2022	4
2023	4
2024	2

1

Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience.

Szatmári S, Szász JA, Orbán-Kis K, Baróti B, Bataga S, Ciorba M, Nagy EE, Neagoe RM, Mihály I, Szász PZ, Kelemen K, Frigy A, Szilveszter M, Constantin VA. Szatmári S, et al. Pharmaceutics. 2024 Mar 25;16(4):453. doi: 10.3390/pharmaceutics16040453. Pharmaceutics. 2024. PMID: 38675114 Free PMC article.

2

Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.

Szatmári S, Szász JA, Orbán-Kis K, Bataga S, Ciorba M, Nagy E, Neagoe R, Mihály I, Szász PZ, Kelemen K, Frigy A, Csipor-Fodor A, Constantin VA. Szatmári S, et al. Sci Rep. 2024 Feb 14;14(1):3676. doi: 10.1038/s41598-024-54299-z. Sci Rep. 2024. PMID: 38355970 Free PMC article.

3

Soft x-ray Ar ^+ 8 laser excited by low-voltage capillary discharge.

Fekete B, Kiss M, Shapolov AA, Szatmari S, Kukhlevsky SV. Fekete B, et al. Among authors: szatmari s. Opt Express. 2023 Oct 9;31(21):34381-34390. doi: 10.1364/OE.498927. Opt Express. 2023. PMID: 37859195 Free article.

4

The impact of SARS-CoV-2 infection on the outcome of acute ischemic stroke-A retrospective cohort study.

Takács TT, Berki ÁJ, Böjti PP, Stang R, Fritz-Reunes PA, Schnekenberg L, Siepmann T, Pintér A, Szatmári S, Bereczki D, Gunda B. Takács TT, et al. Among authors: szatmari s. PLoS One. 2023 Mar 2;18(3):e0282045. doi: 10.1371/journal.pone.0282045. eCollection 2023. PLoS One. 2023. PMID: 36862706 Free PMC article.

5

Two-Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individuals.

Siepmann T, Arndt M, Sedghi A, Szatmári S Jr, Horváth T, Takáts A, Bereczki D, Moskopp ML, Buchmann S, Skowronek C, Zago W, Woranush W, Lapusca R, Weidemann ML, Gibbons CH, Freeman R, Reichmann H, Puetz V, Barlinn K, Pintér A, Illigens BM. Siepmann T, et al. Among authors: szatmari s jr. Eur J Neurol. 2023 May;30(5):1281-1292. doi: 10.1111/ene.15733. Epub 2023 Feb 24. Eur J Neurol. 2023. PMID: 36773001

6

Sub-ps Laser Deposited Copper Films for Application in RF Guns.

Lorusso A, Kovács Z, Gilicze B, Szatmári S, Perrone A, Szörényi T. Lorusso A, et al. Among authors: szatmari s. Materials (Basel). 2023 Feb 2;16(3):1267. doi: 10.3390/ma16031267. Materials (Basel). 2023. PMID: 36770274 Free PMC article.

7

A Rare Case of Histopathologically Confirmed Creutzfeldt-Jakob Disease from Romania, Long Route to Diagnosis-Case Report and an Overview of the Romanian CJD Situation.

Kelemen K, Kövecsi A, Banias L, Klára I, Mihály I, Forró C, Szász JA, Szatmári S. Kelemen K, et al. Among authors: szatmari s. J Clin Med. 2022 Aug 17;11(16):4803. doi: 10.3390/jcm11164803. J Clin Med. 2022. PMID: 36013055 Free PMC article.

8

[Ten-year trends of the characteristics in patients with advanced Parkinson's disease at the time of intestinal gel therapy introduction].

Szász JA, Szatmári S, Constantin V, Mihály I, Török Á, Frigy A, Metz J, Kelemen K, Szász RM, Forró T, Baróti B, Orbán-Kis K. Szász JA, et al. Among authors: szatmari s. Orv Hetil. 2022 Jul 24;163(30):1189-1195. doi: 10.1556/650.2022.32534. Print 2022 Jul 24. Orv Hetil. 2022. PMID: 35895443 Hungarian.

9

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Observations and Dilemmas after 10 Years of Real-Life Experience.

Szász JA, Constantin VA, Orbán-Kis K, Bancu LA, Bataga SM, Ciorba M, Nagy E, Neagoe MR, Mihály I, Szász RM, Kelemen K, Simu M, Szatmári S. Szász JA, et al. Among authors: szatmari s. Pharmaceutics. 2022 May 24;14(6):1115. doi: 10.3390/pharmaceutics14061115. Pharmaceutics. 2022. PMID: 35745688 Free PMC article.

10

Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial.

Woodhouse LJ, Appleton JP, Scutt P, Everton L, Wilkinson G, Caso V, Czlonkowska A, Gommans J, Krishnan K, Laska AC, Ntaios G, Ozturk S, Phillips S, Pocock S, Prasad K, Szatmari S, Wardlaw JM, Sprigg N, Bath PM; ENOS Investigators. Woodhouse LJ, et al. Among authors: szatmari s. EClinicalMedicine. 2022 Jan 24;44:101274. doi: 10.1016/j.eclinm.2022.101274. eCollection 2022 Feb. EClinicalMedicine. 2022. PMID: 35112073 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year